Purchase Order HHSN272201600865P
- Not listed
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,356 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of isolation kits. This award is not associated with a set-aside program. Miltenyi Biotec provides specialized instruments, reagents, and services to support biomedical research and cell therapy development. Through this contract, the company will supply the NIAID with the necessary products for...
- This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, is a one-time maintenance purchase order valued at $3,425.00. The contract was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and did not have a set-aside designation. Miltenyi Biotec is an experienced federal contractor, having previously received awards from various agencies including the NIH, Department of Veterans Affairs,...
- This federal contract award to Miltenyi Biotec, Inc. is for the delivery of dissociation kits, isolation kits, and columns. The $9,617.00 firm fixed price purchase order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The award is not associated with a set-aside program and the ultimate completion date was September 30, 2017. Miltenyi Biotec, a global biotechnology company, has extensive experience...
- This federal contract award to Miltenyi Biotec, Inc. is a $5,400 firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is not set aside and has an ultimate completion date of May 15, 2013. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is valued at $4,058.00 and provides for the delivery of Miltenyi Biotec's dissociation kits, buffers, and antibodies. This award is not associated with a set-aside designation....
- This is a $8,379.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of biomaterials. The award is not designated as a set-aside contract. Miltenyi Biotec is a prime contractor that frequently supports federal biomedical research programs with its specialized cell separation, analysis, and processing technologies, including flow cytometers, cell sorters, and...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $14,577 firm-fixed-price purchase order is for the supply of microbeads and columns for the MACS cell separation system, which is used to support biomedical research and cell therapy development programs at the NIH Clinical Center. This award is part of a larger indefinite...
- This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, was made by the National Institutes of Health (NIH). The $12,867 firm fixed-price purchase order covers the supply of Miltenyi antibodies, cell separation starter kits, and related consumables. Miltenyi Biotec has an extensive history as a prime contractor for numerous federal agencies, including the NIH, Department of Veterans Affairs, and Department of Defense, providing a range of specialized laboratory...
- This is a $3,641 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract does not have a set-aside designation. The award supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables include the supply of FDA-approved,...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $51,351.50 Firm Fixed Price contract is for the supply of CD4 and CD8 microbeads and cell isolation kits. The award was not made under any set-aside program. The contract is likely part of a larger indefinite delivery contract (IDC) that Miltenyi Biotec holds with the NIH Clinical Center, valued at $2.3...
This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $4,566.00 firm fixed-price purchase order is for the delivery of an Isolation Kit and Isolation Beads, with a completion date of July 8, 2016. The contract is not designated as a set-aside award. Miltenyi Biotec is an experienced federal contractor, having previously provided specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation for numerous government agencies, including the NIH, Department of Veterans Affairs, Food and Drug Administration, Department of Defense, and others. Additionally, Miltenyi Biotec holds a significant $2.3 million indefinite delivery contract (IDC) with the NIH Clinical Center, awarded in June 2023, to supply proprietary CliniMACS cell isolation reagents and consumables to support the center's cell processing and manufacturing capabilities for investigational cell therapy products used in NIH clinical trials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | ($49) | 11/2/16 | |
| Not listed | Not listed | $4.6k | 7/1/16 |